Applied DNA Sciences Statistics
Total Valuation
APDN has a market cap or net worth of $2.39 million. The enterprise value is -$3.96 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
| Earnings Date | May 15, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
APDN has 433,186 shares outstanding. The number of shares has increased by 4,995.19% in one year.
| Current Share Class | 433,186 |
| Shares Outstanding | 433,186 |
| Shares Change (YoY) | +4,995.19% |
| Shares Change (QoQ) | +181.27% |
| Owned by Insiders (%) | 1.16% |
| Owned by Institutions (%) | 8.36% |
| Float | 428,163 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| Forward PS | 0.81 |
| PB Ratio | 0.22 |
| P/TBV Ratio | 0.31 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.05.
| Current Ratio | 4.45 |
| Quick Ratio | 3.97 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -148.66% and return on invested capital (ROIC) is -141.59%.
| Return on Equity (ROE) | -148.66% |
| Return on Assets (ROA) | -73.41% |
| Return on Invested Capital (ROIC) | -141.59% |
| Return on Capital Employed (ROCE) | -117.07% |
| Revenue Per Employee | $78,971 |
| Profits Per Employee | -$962,233 |
| Employee Count | 48 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 6.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.58% in the last 52 weeks. The beta is 0.05, so APDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | -98.58% |
| 50-Day Moving Average | 13.81 |
| 200-Day Moving Average | 261.63 |
| Relative Strength Index (RSI) | 22.63 |
| Average Volume (20 Days) | 121,654 |
Short Selling Information
| Short Interest | 787,520 |
| Short Previous Month | 489,146 |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.44 |
Income Statement
In the last 12 months, APDN had revenue of $3.79 million and -$46.19 million in losses. Loss per share was -$944.52.
| Revenue | 3.79M |
| Gross Profit | 1.55M |
| Operating Income | -13.04M |
| Pretax Income | -7.29M |
| Net Income | -46.19M |
| EBITDA | -12.66M |
| EBIT | -13.04M |
| Loss Per Share | -$944.52 |
Full Income StatementBalance Sheet
The company has $6.82 million in cash and $472,390 in debt, giving a net cash position of $6.35 million or $14.66 per share.
| Cash & Cash Equivalents | 6.82M |
| Total Debt | 472,390 |
| Net Cash | 6.35M |
| Net Cash Per Share | $14.66 |
| Equity (Book Value) | 10.22M |
| Book Value Per Share | 24.78 |
| Working Capital | 6.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.25 million and capital expenditures -$695,274, giving a free cash flow of -$13.95 million.
| Operating Cash Flow | -13.25M |
| Capital Expenditures | -695,274 |
| Free Cash Flow | -13.95M |
| FCF Per Share | -$32.20 |
Full Cash Flow StatementMargins
Gross margin is 40.76%, with operating and profit margins of -344.11% and -194.18%.
| Gross Margin | 40.76% |
| Operating Margin | -344.11% |
| Pretax Margin | -197.04% |
| Profit Margin | -194.18% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4,995.19% |
| Shareholder Yield | -4,995.19% |
| Earnings Yield | -1,935.06% |
| FCF Yield | -584.46% |
Analyst Forecast
The average price target for APDN is $1,125.00, which is 20,317.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $1,125.00 |
| Price Target Difference | 20,317.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 2, 2025. It was a reverse split with a ratio of 0.0666667:1.
| Last Split Date | Jun 2, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.0666667:1 |
Scores
APDN has an Altman Z-Score of -38.92 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -38.92 |
| Piotroski F-Score | 3 |